Skip to main content

Federal Judge Grants Summary Judgment in a Risperdal Lawsuit

Federal Judge Grants Summary Judgment in a Risperdal Lawsuit

Federal Judge Grants Summary Judgment in a Risperdal Lawsuit

Introduction

U.S. District Judge Denise J. Casper ruled in favor of Johnson & Johnson and its subsidiary Janssen Pharmaceuticals Inc. on Wednesday over claims by a Bay State man that the antipsychotic drug Risperdal caused him to gain excessive weight during his teenage years.

The lawsuit, filed by a man and his parents, lacked the backing of a medical expert to support their claim that Risperdal intake led to his unusual weight gain. Risperdal lawsuits filed across the U.S. accuse Johnson & Johnson and its affiliates of illegally marketing the product even after being aware of its gynecomastia risk. Individuals affected also claim the drug makers failed to warn that it is no more effective and comparatively less safe than other antipsychotic medications.

Over 7,000 Risperdal product liability lawsuits are filed in the Pennsylvania State Court against Janssen and its parent company J&J. Two coordinated actions have been filed for Risperdal cases: one in Los Angeles Superior Court (Risperdal and Invega Product Liability Cases, JCCP 4775) and the other in Philadelphia (In Re: Risperdal Litigation, March 2010 Term, Case No. 100300296).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!